CompoAtlas

EPAM - 11 (Paziņots 2008.)

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000087/2008
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
AK-88, SIA
Manufacturer
name not reproduced (no recognised company form)
Origin
Latvija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
Pa 10 - 20 pilieniem 3 reizes dienā
Published pack size
30 ml
Published packaging
Plastmasas pudelīte 30 ml

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
Klusā okeāna bergēnijas sakneņa ekstrakts 1:3plants ; Klusā okeāna bergēnijas sakneņa ekstrakts 1:3 ; Bergenia crassifolia ; 0,42 ; mlbergenia crassifoliaPlant
Parastā pelašķa lakstu ekstrakts 1:2plants ; Parastā pelašķa lakstu ekstrakts 1:2 ; Achillea millefolium ; 0,54 ; mlachillea millefoliumPlant
Lielās ceļtekas lapu ekstrakts 1:2plants ; Lielās ceļtekas lapu ekstrakts 1:2 ; Plantago major ; 0,56 ; mlplantago majorPlant
Nātres lapu ekstrakts 1:2plants ; Nātres lapu ekstrakts 1:2 ; Urtica dioica ; 0,68 ; mlurtica dioicaPlant
Trejkrāsu vijolītes lakstu ekstrakts 1:4plants ; Trejkrāsu vijolītes lakstu ekstrakts 1:4 ; Viola tricolor ; 0,17 ; mlviola tricolorPlant
Ārstniecības salvijas lapu ekstrakts 1:5plants ; Ārstniecības salvijas lapu ekstrakts 1:5 ; Salvia officinalis ; 0,53 ; mlsalvia officinalisPlant
Piparmētras lapu ekstrakts 1:4plants ; Piparmētras lapu ekstrakts 1:4 ; Mentha piperita ; 0,74 ; gmentha piperitaPlant
Smaržīgās kalmes sakneņa ekstrakts 1:6plants ; Smaržīgās kalmes sakneņa ekstrakts 1:6 ; Acorus calamus ; 0,57 ; mlacorus calamusPlant
Ārstniecības pienenes saknes ekstrakts 1:2plants ; Ārstniecības pienenes saknes ekstrakts 1:2 ; Taraxacum officinale ; 0,70 ; mlNot recognisedRole not identified
Blīvās skābenes lakstu ekstrakts 1:4plants ; Blīvās skābenes lakstu ekstrakts 1:4 ; Rumex confertus ; 0,92 ; mlNot recognisedRole not identified
Kukurūzas drīksnu ekstrakts 1:5plants ; Kukurūzas drīksnu ekstrakts 1:5 ; Zea mays ; 0,46 ; mlzea maysPlant
Kailās lakricas saknes ekstrakts 1:4plants ; Kailās lakricas saknes ekstrakts 1:4 ; Glycyrrhiza glabra ; 0,62 ; mlglycyrrhiza glabraPlant
Muskatrieksta ūdens-spirta ekstrakts 1:2plants ; Muskatrieksta ūdens-spirta ekstrakts 1:2 ; Myristica fragrans ; 0,89 ; mlmyristica fragransPlant
Kālija sorbāts (E 202)otherIngredients ; Kālija sorbāts (E 202)Not recognisedRole not identified
Glicerīns (E 422)otherIngredients ; Glicerīns (E 422)Not recognisedRole not identified
Propolisa tinktūraotherIngredients ; Propolisa tinktūra ; 4,8 ; mlNot recognisedRole not identified
ŪdensotherIngredients ; ŪdensNot recognisedRole not identified
EtilspirtsotherIngredients ; EtilspirtsNot recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Krievija

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Nātres lapu ekstrakts 1:2
    Read the warning, when it applies and the studies cited

    STINGING NETTLE JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products except those making only a diuretic claim*.

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

    STINGING NETTLE - URTICA DIOICA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except nutritive tonics.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Tilgner 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    All products except those making only a diuretic claim*

    When using this product diuretic effect may occur.

    *Note: This statement can be removed from the label if a diuretic claim is included.

    Health Canada monograph dated 27 March 2026

  • Ārstniecības salvijas lapu ekstrakts 1:5
    Read the warning, when it applies and the studies cited

    SAGE - SALVIA OFFICINALIS - Buccal

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    SAGE -SALVIA OFFICINALIS Oral

    Cautions and warnings

    Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

  • Piparmētras lapu ekstrakts 1:4
    Read the warning, when it applies and the studies cited

    PEPPERMINT - MENTHA X PIPERITA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 February 2026

  • Kailās lakricas saknes ekstrakts 1:4
    Read the warning, when it applies and the studies cited

    DEGLYCYRRHIZINATED LICORICE Buccal

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 October 2025

    Deglycyrrhizinated Licorice Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 31 January 2025

    LICORICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Gardner and McGuffin 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Cough relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if cough worsens or persists (for) more than 1 week (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Gastritis relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant (EMA 2012).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have hypokalemia, high blood pressure, or a kidney, liver or cardiovascular disorder (EMA 2012; Brinker 2010; ESCOP 2003; Bradley 1992).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you are taking heart medications, corticosteroids, stimulant laxatives, or other health products that may contribute electrolyte imbalance (Brinker 2010; ESCOP 2003; Hoffmann 2003; Blumenthal et al. 2000).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line